NCT03493841View on ClinicalTrials.gov

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

January 25, 2019

Study Completion Date

January 25, 2019

Conditions

Multiple SclerosisProgressive Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis

Interventions

DRUG

Alpha Lipoic Acid

Lipoic acid is an over the counter supplement. Two different forms, R and racemic are available. R-lipoic acid is the naturally occurring form. Racemic lipoic acid is the most commonly available supplement.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Rebecca Spain

OTHER

NCT03493841 - Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter